| Name | Title | Contact Details |
|---|
Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. At Olema we leverage the exquisite knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development.
Envigen Pharmaceuticals is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Anuncia Medical, Inc., an emerging leader in Cerebrospinal Fluid (CSF) management
BHE is an independent health analytics company with over two decades of experience in designing and conducting research that assesses the value of medical technologies.